STX17 and renal cell carcinoma: For instance, as discussed earlier, Pan et al. (2025) discovered that STX17-DT, beyond its intrinsic role in TKI resistance within RCC cells, could be packaged into EVs via hnRNPA1, enabling the transmission of axitinib resistance to other cells[48].